TherapeuticsMD, Inc. Business Finance Contracts & Agreements
83 Contracts & Agreements
- Credit Agreements (2 contracts)
- Escrow Agreements (4)
- Financing Agreements (4)
- Guaranty Agreements (2)
- Investment Agreements (1)
- Note Agreements (28)
- Purchase Agreements (1)
- Registration Rights Agreements (1)
- Security Agreements (8)
- Stock Agreements (4)
- Subscription Agreements (4)
- Underwriting Agreements (12)
- Warrant Agreements (12)
- Subscription Agreement by and among TherapeuticsMD, Inc., Sixth Street Specialty Lending, Inc., TOP IV Talents, LLC and TAO Talents, LLC, dated October 28, 2022 (Filed With SEC on October 31, 2022)
- Subscription Agreement by and among TherapeuticsMD, Inc., Sixth Street Specialty Lending, Inc., TOP IV Talents, LLC and TAO Talents, LLC, dated September 30, 2022 (Filed With SEC on October 3, 2022)
- Amendment No. 16 to Financing Agreement, dated July 29, 2022, by and among TherapeuticsMD, Inc., VitaMedMD, LLC, BocagreenMD, Inc., Sixth Street Specialty Lending, Inc., Top IV... (Filed With SEC on August 1, 2022)
- Subscription Agreement by and among TherapeuticsMD, Inc., Sixth Street Specialty Lending, Inc., TOP IV Talents, LLC and TOA Talents, LLC, dated July 29, 2022 (Filed With SEC on August 1, 2022)
- Amendment No. 10 to Financing Agreement, dated May 27, 2022, by and among TherapeuticsMD, Inc., VitaMedMD, LLC, BocagreenMD, Inc., Sixth Street Specialty Lending, Inc., Top IV... (Filed With SEC on May 31, 2022)
- Stock Purchase Agreement, dated as of March 6, 2022, by and between TherapeuticsMD, Inc. and GoodRx, Inc (Filed With SEC on March 10, 2022)
- Amendment to Warrant issued by the Company to John C.K. Milligan, IV (Filed With SEC on March 4, 2021)
- Warrant issued by the Company to John C.K. Milligan, IV (Filed With SEC on March 4, 2021)
- Amendment to Warrant issued by the Company to Robert Finizio (Filed With SEC on March 4, 2021)
- Warrant issued by the Company to Robert Finizio (Filed With SEC on March 4, 2021)
- Second Amendment to Company Warrant issued by the Company to the Subscribers party to that certain Subscription Agreement, dated as of August 5, 2020 (Filed With SEC on March 4, 2021)
- Underwriting Agreement, dated February 11, 2021, by and between the Company and Cantor Fitzgerald & Co., as representative of the several underwriters named therein (Filed With SEC on February 16, 2021)
- Underwriting Agreement, dated November 10, 2020, by and between the Company and Cantor Fitzgerald & Co., as representative of the several underwriters named therein (Filed With SEC on November 13, 2020)
- Amendment to Form of Warrant to Purchase Common Stock issued by TherapeuticsMD, Inc. to the Subscribers party to that certain Subscription Agreement, dated as of August 5, 2020 (Filed With SEC on November 9, 2020)
- Subscription Agreement, by and among TherapeuticsMD, Inc. and the Subscribers identified on the Schedule of Subscribers attached thereto (Filed With SEC on August 7, 2020)
- Form of Warrant to Purchase Common Stock issued by TherapeuticsMD, Inc. to the Subscribers party to that certain Subscription Agreement, dated as of August 5, 2020 (Filed With SEC on August 7, 2020)
- Underwriting Agreement, dated October 24, 2019, by and between the Company and J.P. Morgan Securities LLC, as representative of the several underwriters named therein (Filed With SEC on October 29, 2019)
- Amendment No. 1 to the Credit and Security Agreement, by and among TherapeuticsMD, Inc., as borrower, its subsidiaries party thereto from time to time, each as a borrower, MidCap... (Filed With SEC on November 8, 2018)
- Underwriting Agreement, dated August 1, 2018, by and between the Company and Goldman Sachs & Co. LLC, as representative of the several underwriters named therein (Filed With SEC on August 3, 2018)
- Underwriting Agreement, dated September 25, 2017, by and between the Company and J.P. Morgan Securities LLC (Filed With SEC on September 28, 2017)
- TherapeuticsMD, Inc. Common Stock Underwriting Agreement (Filed With SEC on January 12, 2016)
- THERAPEUTICSMD, INC. $30,000,001.20 COMMON STOCK UNDERWRITING AGREEMENT (Filed With SEC on July 15, 2015)
- THERAPEUTICSMD, INC. $54,999,996.30 COMMON STOCK UNDERWRITING AGREEMENT (Filed With SEC on February 17, 2015)
- TherapeuticsMD, Inc. Common Stock Underwriting Agreement (Filed With SEC on August 4, 2014)
- 9,000,000 Shares TherapeuticsMD, Inc. UNDERWRITING AGREEMENT (Filed With SEC on March 21, 2014)
- 13,750,000 Shares TherapeuticsMD, Inc. UNDERWRITING AGREEMENT (Filed With SEC on September 25, 2013)
- AGREEMENT TO FORFEIT NON-QUALIFIED STOCK OPTIONS (Filed With SEC on May 10, 2013)
- 29,411,765 Shares TherapeuticsMD, Inc. UNDERWRITING AGREEMENT (Filed With SEC on March 15, 2013)
- Common Stock Purchase Warrant, issued to Plato & Associates, LLC (Filed With SEC on February 6, 2013)
- Multiple Advance Revolving Credit Note, issued to Plato & Associates, LLC (Filed With SEC on February 6, 2013)
- Secured Promissory Note between the Company and Johnson and Plato, form of (Filed With SEC on November 13, 2012)
- Securities Purchase Agreement, form of (Filed With SEC on October 2, 2012)
- Common Stock Purchase Warrant, form of (Filed With SEC on June 21, 2012)
- Security Agreement (Filed With SEC on June 21, 2012)
- Secured Promissory Note, form of (Filed With SEC on June 21, 2012)
- Note Purchase Agreement (Filed With SEC on June 21, 2012)
- Common Stock Purchase Warrant, form of (Filed With SEC on February 24, 2012)
- Security Agreement (Filed With SEC on February 24, 2012)
- Secured Promissory Note, form of (Filed With SEC on February 24, 2012)
- Note Purchase Agreement (Filed With SEC on February 24, 2012)
